A comparison of the pharmacological properties of guinea‐pig and human recombinant 5‐HT4receptors
Authors:
- 1 March 2007
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 150 (6) , 782-791
Abstract
Background and purpose: 5‐HT4receptor agonists are used therapeutically to treat disorders of reduced gastrointestinal motility. Since such compounds are evaluated in guinea‐pigs, we cloned, expressed and pharmacologically characterized the guinea‐pig 5‐HT4and human 5‐HT4(b)splice variant, which share 95% homology. The functional properties of guinea‐pig 5‐HT4(b)receptors were compared with native receptors in guinea‐pig colon.Experimental approach: Membrane radioligand binding and whole cell cAMP accumulation assays were used to determine the affinities, potencies and intrinsic activities (IA). Contraction of the guinea‐pig distal colon longitudinal muscle myenteric plexus preparation (LMMP) was monitored to evaluate functional activity.Key results: pKivalues for guinea‐pig and human recombinant receptors, and guinea‐pig striatum 5‐HT4receptors, were in agreement, as were the potency and IA values for guinea‐pig and human 5‐HT4receptors expressed at a similar density (∼0.2 pmol mg−1protein). Tegaserod was a potent (pEC50=8.4 and 8.7, respectively), full agonist at both guinea‐pig and human 5‐HT4receptors. In contrast, in the LMMP preparation, tegaserod was a potent, partial agonist (pEC50=8.2; IA=66%).Conclusions and implications: Close agreement between the pharmacological properties of guinea‐pig and human 5‐HT4receptors support the use of guinea‐pig model systems for the identification of 5‐HT4receptor therapeutics. However, the mechanisms underlying the different agonist properties of tegaserod in recombinant and isolated tissue preparations, and the extent to which these impact the clinical efficacy of tegaserod as a prokinetic agent, remain to be determined.British Journal of Pharmacology(2007)150, 782–791. doi:10.1038/sj.bjp.0707154Keywords
This publication has 59 references indexed in Scilit:
- Identification of neurons that express 5-hydroxytryptamine4 receptors in intestineCell and tissue research, 2006
- Review article: tegaserod for chronic constipationAlimentary Pharmacology & Therapeutics, 2004
- Characterization of human 5-HT4(d)receptor desensitization in CHO cellsBritish Journal of Pharmacology, 2003
- Ras-dependent ERK Activation by the Human Gs-coupled Serotonin Receptors 5-HT4(b) and 5-HT7(a)Journal of Biological Chemistry, 2003
- Presynaptic modulation of cholinergic neurotransmission in the human proximal stomachBritish Journal of Pharmacology, 2002
- TegaserodJournal of Clinical Gastroenterology, 2002
- Differences in Signal Transduction of Two 5-HT4Receptor Splice Variants: Compound Specificity and Dual Coupling with Gαs- and Gαi/o-ProteinsMolecular Pharmacology, 2002
- Identification and characterization of the 5-HT4 receptor in the intestinal tract and striatum of the guinea pigLife Sciences, 1996
- 5-HT4 receptors in rat but not guinea pig, rabbit or dog esophageal smooth muscleGeneral Pharmacology: The Vascular System, 1994
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973